Skip to content
Life Sciences Series A Founded 2018

iVexSol

IVexSol is a manufacturer and developer of the vector. It offers its flagship intelligent transformative platform for developing lentiviral vector cell lines. Developer of a platform for the production of vectors. Operating in the Life Sciences > Life Sciences Platforms and Tools, Life Sciences > Genomics sector. with business models spanning Genomics > Enabling Technologies > Technology Platforms > Gene Delivery,…

📍 Toronto, Canada · Life Sciences Platforms and Tools,

Funding snapshot

Last roundSeries A
Amount$24M
Date26 January 2023
Total raised$39M
Team size3

About

IVexSol is a manufacturer and developer of the vector. It offers its flagship intelligent transformative platform for developing lentiviral vector cell lines. Developer of a platform for the production of vectors. Operating in the Life Sciences > Life Sciences Platforms and Tools, Life Sciences > Genomics sector. with business models spanning Genomics > Enabling Technologies > Technology Platforms > Gene Delivery, Life Sciences Platforms and Tools > Research Services > Diversified. Founded in 2018, headquartered in Toronto, Canada. The company has raised $39.0M at the Series A stage, backed by investors including Massachusetts Life Sciences Center, Bristol-Myers Squibb, Charles River Laboratories, Asahi Kasei, Casdin Capital.

Business model

Genomics > Enabling Technologies > Technology Platforms > Gene Delivery,

Life Sciences Platforms and Tools > Research Services > Diversified

Institutional investors

Massachusetts Life Sciences Center Bristol-Myers Squibb Charles River Laboratories Asahi Kasei Casdin Capital BioLife Solutions Massachusetts Biomedical Initiatives

Latest coverage

No articles yet.

Raising like iVexSol?

Analyze your pitch deck before your next raise.

Analyze My Deck →